You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
|
|---|---|
| Published in |
Malaria Journal, August 2012
|
| DOI | 10.1186/1475-2875-11-299 |
| Pubmed ID | |
| Authors |
Prashant Yadav, Jessica L Cohen, Sarah Alphs, Jean Arkedis, Peter S Larson, Julius Massaga, Oliver Sabot |
| Abstract |
The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy program that aims to increase access and affordability of artemisinin combination therapy (ACT) in public sector clinics and private retail shops. It is unclear to what extent the AMFm model will translate into wide scale availability and price reductions in ACT, particularly for rural, remote areas where disparities in access to medicines often exist. This study is the first to rigorously examine the availability and price of subsidized ACT during the first year of the AMFm, measured through retail audits in remote regions of Tanzania. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| United States | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| United States | 1 | 1% |
| Norway | 1 | 1% |
| Vietnam | 1 | 1% |
| Unknown | 70 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 20% |
| Student > Master | 11 | 15% |
| Lecturer | 6 | 8% |
| Other | 5 | 7% |
| Student > Doctoral Student | 4 | 5% |
| Other | 15 | 20% |
| Unknown | 18 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 22% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
| Social Sciences | 7 | 9% |
| Agricultural and Biological Sciences | 6 | 8% |
| Nursing and Health Professions | 4 | 5% |
| Other | 16 | 22% |
| Unknown | 18 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2021.
All research outputs
#7,147,830
of 25,271,884 outputs
Outputs from Malaria Journal
#1,843
of 5,888 outputs
Outputs of similar age
#48,960
of 178,284 outputs
Outputs of similar age from Malaria Journal
#17
of 81 outputs
Altmetric has tracked 25,271,884 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 5,888 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,284 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.